Phase III comparative study of high-dose cisplatin (HD-CIS) versus a combination of paclitaxel (TAX) and cisplatin (CIS) in patients with advanced non-small-cell lung cancer (NSCLC) - Gatzmeier,U.; von Pawel,J.; Gottfried,M. (Proc Am Soc Clin Oncol, 1998)